Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of …

JD Brunzell, M Davidson, CD Furberg… - Journal of the American …, 2008 - jacc.org
Risk factors for type 2 diabetes and cardiovascular disease (CVD) often cluster, including
obesity (particularly central), insulin resistance, hyperglycemia, dyslipoproteinemia, and …

Management of dyslipidemia in diabetes

MP Solano, RB Goldberg - Cardiology in review, 2006 - journals.lww.com
Diabetes is associated with a high risk of cardiovascular disease. The management of
dyslipidemia, a well-recognized and modifiable risk factor among patients with type 2 …

Managing dyslipidemia in the high-risk patient

EA Stein - The American journal of cardiology, 2002 - Elsevier
Lipid-lowering agents have been shown to reduce morbidity and mortality associated with
coronary artery disease (CAD) in all patients. However, these agents are more cost-effective …

Role of lipid and lipoprotein profiles in risk assessment and therapy

CM Ballantyne, RC Hoogeveen - American heart journal, 2003 - Elsevier
Although low-density lipoprotein cholesterol (LDL-C) remains the primary target for coronary
heart disease (CHD) prevention in the latest guidelines of the National Cholesterol …

Management of dyslipidemia in adults with diabetes

SM Haffner - Diabetes care, 1998 - Am Diabetes Assoc
Subjects with diabetes have a greatly increased risk of CHD, which is only partially related to
their elevated glucose. Other factors such as insulin resistance and dyslipidemia are likely to …

Dyslipidemia in type 2 diabetes mellitus

R Gadi, FF Samaha - Current diabetes reports, 2007 - Springer
Cardiovascular disease is a significant cause of morbidity and mortality in patients with
diabetes mellitus (DM). DM is now recognized as a risk equivalent for coronary heart …

Diabetes dyslipidemia

JD Schofield, Y Liu, P Rao-Balakrishna, RA Malik… - Diabetes therapy, 2016 - Springer
Diabetes mellitus is associated with a considerably increased risk of premature
atherosclerotic cardiovascular disease. Intensive glycemic control has essentially failed to …

Low-density lipoproteins and risk for coronary artery disease

CM Ballantyne - The American journal of cardiology, 1998 - Elsevier
Based on the established relation between low-density lipoprotein (LDL) cholesterol and
coronary artery disease (CAD), the treatment guidelines of the US National Cholesterol …

Contemporary management of dyslipidemia in high-risk patients: targets still not met

AT Yan, RT Yan, M Tan, DG Hackam… - The American journal of …, 2006 - Elsevier
PURPOSE: Our objective was to evaluate treatment patterns and the attainment of current
National Cholesterol Education Program (NCEP)-recommended lipid targets in unselected …

Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management

G Assmann - The American journal of cardiology, 2001 - Elsevier
Risk assessment limited to low-density lipoprotein cholesterol (LDL-C) levels fails to identify
a substantial proportion of individuals at risk for coronary artery disease. Data from the …